Computational Chemistry Approaches to Molecular Docking

2.1 What is molecular docking?

Molecular docking is a computational technique used to predict the preferred orientation and binding affinity of one molecule (typically a small ligand) when it interacts with a second molecule (usually a larger biological macromolecule such as a protein or DNA). The goal is to determine how two molecules fit together in a receptor–ligand complex, much like how a key fits into a lock.

The process simulates the interaction between the molecules to find the most stable configuration – known as the binding pose – which often correlates with biological activity or inhibitory potential. The docking process evaluates multiple orientations and conformations of the ligand in the binding site and scores them based on factors like hydrogen bonding, hydrophobic interactions, van der Waals forces, and electrostatics [12, 13].

Molecular docking is widely used in:

• Structure-based drug design: to identify promising drug candidates

• Enzyme-substrate interaction studies: to model catalysis and inhibition

• Biomolecular interaction mapping: for protein–protein, protein–DNA, and protein–RNA complexes

It is considered a fast and cost-effective alternative to experimental methods, especially in the early stages of drug discovery and molecular analysis.

A dagram (Figure 1) illustrating the molecular docking workflow in computational drug discovery, showing steps such as protein and ligand preparation, docking simulation, scoring and ranking of binding poses and analysis of praotein-lingand interactions.

Protein of interest: at the top, the figure shows a protein structure (ribbon model with helices, sheets, and coils). This protein is the target for docking, usually an enzyme, receptor, or other biomolecule involved in a disease pathway. The protein has an active/binding site (cavity or pocket) where potential ligands can interact as shown in the Figure 1.

Chemical database: the middle section represents a library of chemical compounds (ligands). This database contains thousands to millions of small molecules with diverse chemical structures. The goal is to screen them computationally to determine which ones might fit and bind well into the protein’s active site.

Docking process: docking is a simulation technique where each chemical compound is virtually “fitted” into the protein’s binding site. It predicts binding orientation (how the ligand fits into the site), binding affinity (strength of interaction, usually expressed as docking score or binding energy), and key molecular interactions (hydrogen bonds, hydrophobic contacts, electrostatic interactions, π-π stacking, van der Waals forces, etc.).

Possible binding ligand: at the bottom, the figure shows the protein-ligand complex after docking. The ligand is predicted to bind stably within the protein’s active site. Such a ligand is a potential drug candidate, as it can modulate the protein’s activity (inhibit or activate). This Figure 1 illustrates the workflow of SBDD. The process begins with selecting a protein target of biomedical relevance, followed by virtual screening (VS) of a chemical database through molecular docking. From this, potential ligands with favorable binding interactions are identified for further evaluation.

The Figure 1 explains how molecular docking helps identify new drug candidates by simulating and predicting how different chemical compounds might interact with a target protein at the molecular level. It reduces time and cost compared to experimental screening.

2.2 Types of molecular docking

Molecular docking can be categorized based on the flexibility of the molecules involved:

2.2.2 Flexible docking

Flexible docking allows conformational changes in either the ligand, the receptor, or both. This approach is more realistic as it simulates how molecules behave dynamically in a biological system. There are different levels of flexibility:

• Ligand-flexible docking: only the ligand’s conformation changes

• Receptor-flexible docking: allows side-chain or backbone movements in the protein

• Induced fit docking: both molecules adapt to achieve optimal binding

Flexible docking is more computationally demanding but provides a better approximation of real molecular interactions.

A diagram (Figure 2) showing types of molecular docking studies categorized by receptor and ligand flexibility, including rigid–rigid docking, flexible–ligand docking, flexible–receptor docking, and fully flexible docking approaches.

Rigid docking: in rigid docking, both the receptor and the ligand are treated as fixed, inflexible structures. The assumption is that neither molecule undergoes conformational changes during the binding process. This method is computationally efficient and requires fewer resources, making it suitable for high-throughput screening or initial binding predictions. However, because biological molecules are inherently flexible, rigid docking often lacks accuracy in representing true binding interactions.

Flexible–rigid docking: flexible–rigid docking is a more refined approach, where the receptor is kept rigid while the ligand is allowed to adopt different conformations. This flexibility enables the ligand to adjust its shape to fit into the binding pocket of the receptor. As a result, this method provides a more realistic prediction of binding interactions compared to rigid docking. It is one of the most commonly used approaches in SBDD because it balances computational efficiency with predictive accuracy.

Flexible docking: flexible docking is the most advanced and realistic method, as it allows both the receptor and the ligand to undergo conformational changes during the docking process. This approach as shown in Figure 2 accounts for the dynamic nature of proteins and small molecules, thereby providing highly accurate predictions of binding affinity and orientation. However, the increased accuracy comes at the cost of high computational demand and longer processing times. Flexible docking is particularly valuable for complex systems where receptor flexibility plays a key role in ligand recognition and binding.

The choice of docking method depends on the balance between speed, computational resources, and accuracy required for a given study. Rigid docking is fast but less accurate, flexible–rigid docking provides a practical compromise, and flexible docking offers the most accurate yet computationally expensive predictions. Together, these approaches form the foundation of SBDD and play a critical role in modern drug discovery research.

2.3 Scoring functions in docking

Scoring functions are mathematical models used to predict the strength and stability of the ligand–receptor interaction. After generating multiple binding poses, the docking algorithm uses these functions to rank and select the best pose based on predicted binding affinity [4, 9, 12, 13].

Common types of scoring functions:

1. Force-field-based scoring calculates interaction energies based on physical principles (e.g., van der Waals, electrostatics). Example tools: AutoDock, CHARMM.

2. Empirical scoring combines physical terms with regression models derived from experimental data. Example: ChemScore, GlideScore.

3. Knowledge-BASED SCORING uses statistical data from known protein–ligand complexes to estimate interaction probabilities. Example: DrugScore

4. Consensus scoring combines results from multiple scoring functions to improve accuracy.

While scoring functions are essential, they are often approximate and may fail to capture all energetic and entropic contributions. Therefore, postdocking analyses, such as MD or free energy calculations, are often used for refinement [14].

3.1 Docking algorithms

Docking algorithms typically follow a two-step process:

• Search algorithm: explores different binding modes between the ligand and the receptor.

• Scoring function: evaluates and ranks the binding modes based on the predicted binding affinity.

3.2 Common molecular docking software tools

Common molecular docking software tools—such as AutoDock, AutoDock Vina, DOCK, Glide, and GOLD (as shown in the Table 1)—are widely used in drug discovery and virtual screening to predict how small molecules bind to protein targets. These programs differ in speed, accuracy, flexibility handling, and ease of use. Open-source tools like AutoDock and Vina are popular in academia because they are free, support ligand and limited receptor flexibility, and are suitable for large-scale screening. Commercial tools such as Glide and GOLD often offer higher accuracy and more sophisticated scoring functions, making them useful for detailed binding studies. The choice of software depends on research goals, computational resources, and the level of expertise required. Below is a list of widely used molecular docking programs, each with its own features, algorithms, and applications:

Each of these tools balances speed, accuracy, and usability differently, and the choice of software depends on the research goals, computational resources, and level of expertise.

4.1 Virtual screening of drug libraries

VS is one of the most impactful applications of molecular docking. It involves screening thousands to millions of compounds in silico to identify those most likely to bind effectively with a target protein. Docking is used to:

• Rank compounds based on predicted binding affinity

• Select top hits for synthesis or experimental testing

• Eliminate nonbinders early in the pipeline

There are two major types of VS:

• Structure-based VS: uses the 3D structure of the target (via X-ray crystallography, NMR, or homology modeling)

• Ligand-based VS: relies on known active compounds to predict new candidates when the target structure is unknown

This method is widely used in pharmaceutical industries to fast-track hit identification and reduce false positives in drug discovery pipelines [15, 16, 17].

A workflow diagram (Figure 3) illustrating the virtual screening and docking process, including compound library preparation, filtering and selection, docking simulations, scoring and ranking of hits, and identification of promising lead molecules. The process of structure-based drug discovery often begins with the construction of a virtual compound library. In this step, a collection of small molecules with diverse chemical structures is prepared, either from publicly available chemical databases or through computational design. This library serves as the source of potential ligands that can interact with the biological target.

The next step is molecular docking, where the compounds in the virtual library are computationally fitted into the active site of the target protein. Docking simulations predict the binding orientation, interactions, and binding affinity of each ligand with the receptor. This step helps identify how well a compound can occupy the binding pocket and establish stabilizing interactions, such as hydrogen bonds, hydrophobic interactions, and electrostatic forces as shown in Figure 3.

Following docking, the results undergo VS, in which compounds are ranked based on their predicted binding scores and interaction profiles. This filtering process allows researchers to shortlist the most promising ligands with favorable binding characteristics for further experimental validation. By integrating these steps, the workflow significantly reduces time and cost in the early stages of drug discovery while enhancing the likelihood of identifying effective drug candidates.

4.2 Lead optimization

Once a potential drug candidate (or lead compound) is identified, docking helps in optimizing its structure to improve potency, selectivity, and pharmacokinetic properties. Iterative docking simulations are performed on modified compounds to:

• Improve binding strength (affinity)

• Reduce off-target effects

• Enhance specificity toward a receptor subtype

Tools like Glide and GOLD are particularly useful for this purpose, as they offer high-precision scoring and flexibility in ligand docking.

4.3 Predicting binding modes and interactions

Docking helps visualize how a drug binds to its target, revealing:

• Key binding site residues

• Types of interactions (hydrogen bonds, hydrophobic contacts, π–π stacking, etc.)

• Orientation and conformation of the ligand within the active site

This information is critical in rational drug design, where specific features of a compound are engineered to exploit the structure of the binding pocket [6, 15].

A graphic showing, in Figure 4, how molecular dynamics (MD) simulations validate docking results by tracking the ligand–protein complex over time and using RMSD plots to confirm stable binding interactions. After docking, it is essential to evaluate the stability of the predicted ligand–protein complexes under dynamic conditions. MD simulations provide valuable insights into how a ligand behaves in the binding pocket over time. One of the most commonly used parameters in this analysis is the root mean square deviation (RMSD), which measures the deviation of atomic positions compared to the native (reference) structure as shown in Figure 4.

In the Figure 4, two docking poses are compared based on their RMSD values. The blue trajectory shows a high RMSD value of 6.14 Å, indicating poor stability and significant deviation from the native binding mode. Conversely, the cyan trajectory shows a low RMSD value of 0.67 Å, which suggests strong stability and close agreement with the native structure. The structural snapshots on the left further illustrate how the correct pose remains stably bound within the active site, while the incorrect pose drifts away.

Thus, RMSD analysis during MD simulations is a critical step in distinguishing reliable binding modes from false positives, thereby improving the accuracy of structure-based drug discovery.

4.4 Case studies and real-world impact

Several successful drugs were first identified or optimized using molecular docking methods:

• HIV protease inhibitors (e.g., saquinavir) were developed using structure-guided docking

• Imatinib (Gleevec), used in chronic myeloid leukemia, benefited from docking in kinase binding analysis

• COVID-19 antiviral candidates were rapidly screened using AutoDock and other tools

These real-world examples highlight how molecular docking transforms drug discovery from a trial-and-error process into a targeted, hypothesis-driven workflow.

5.1 Understanding enzyme–substrate interactions

Molecular docking is frequently used to study how enzymes recognize and bind their natural substrates. By simulating these interactions, researchers can:

• Identify key active site residues

• Visualize the orientation of the substrate within the catalytic pocket

• Understand binding specificity and reaction mechanism pathways

This knowledge forms the foundation for modifying enzyme selectivity or improving substrate turnover in industrial or therapeutic enzymes.

A diagram (Figure 5) illustrating the formation of the enzyme–substrate complex, showing a substrate molecule fitting into the enzyme’s active site to form a temporary bound complex before catalysis occurs. Enzymes are biological catalysts that accelerate chemical reactions by binding to specific substrates. Each enzyme contains an active site, a region with a unique shape complementary to the substrate. The substrate fits into the active site much like a key fits into a lock, ensuring specificity of the reaction.

When the substrate binds to the enzyme’s active site, they form an enzyme–substrate complex as shown in Figure 5. This complex stabilizes the transition state and lowers the activation energy required for the reaction. As a result, the reaction proceeds more efficiently, converting the substrate into the product. Once the reaction is complete, the enzyme releases the product and is free to catalyze another reaction cycle.

This Figure 5 shows the substrate binding to the enzyme’s active site and the subsequent formation of the enzyme–substrate complex, highlighting the basis of enzyme catalysis and specificity.

5.2 Rational enzyme design

With molecular docking, scientists can rationally design enzymes to:

• Accept nonnatural substrates

• Improve catalytic efficiency

• Alter regioselectivity or stereoselectivity

• Enhance stability under extreme conditions (e.g., temperature, pH)

By docking modified substrates or potential transition states into mutant enzyme models, researchers can predict how amino acid changes affect binding and catalysis – before doing any experimental work.

Example: engineering lipases or esterases to better accept bulky ester substrates for use in biofuel production.

5.3 Enzyme inhibition and allosteric modulation

Molecular docking helps in designing or analyzing enzyme inhibitors – whether competitive, noncompetitive, or allosteric. It can:

• Identify potential binding pockets outside the active site

• Predict conformational changes upon binding

• Guide the design of small-molecule regulators for therapeutic enzymes

For example, docking has been used to identify allosteric inhibitors of kinases and proteases, offering a strategy to modulate enzyme function without directly competing with substrates.

5.4 Integration with mutagenesis and experimental validation

In silico docking studies are often paired with site-directed mutagenesis and enzyme kinetics experiments to validate and refine predictions. This synergy allows for:

• Prioritizing mutations for laboratory testing

• Reducing the number of experimental iterations

• Gaining structural explanations for observed functional changes

5.5 Case study: Docking in industrial biocatalysts

A notable application is the use of docking in the development of enzymes for industrial catalysis, such as:

• Proteases used in detergents

• Amylases for starch processing

• Dehydrogenases for stereoselective synthesis

Molecular docking helps identify which enzyme variants bind better to synthetic or chiral substrates, thus accelerating the path from laboratory design to industrial application.

6.1 Importance of protein–protein and protein–DNA docking

• Protein–protein interactions (PPIs): regulate key cellular processes, such as signal transduction, metabolic pathways, and immune recognition.

• Protein–DNA interactions: control gene expression, replication, and repair mechanisms.

Understanding these interactions at the molecular level is crucial for designing therapeutic inhibitors, synthetic biology applications, and deciphering biological networks.

This image illustrates the workflow of protein–DNA/RNA docking interactions, which is a computational approach to predict how a protein binds to nucleic acids. Let’s break it down step-by-step.

A workflow diagram illustrating the steps in protein–DNA/RNA docking interactions, including structure preparation of the protein and nucleic acid, selection of docking software, docking simulation, scoring and ranking of poses, and final analysis of predicted binding interactions.

Input molecules: protein (shown as a ribbon diagram in red) and DNA or RNA (shown as the helical structure). These two are the starting molecules whose interaction we want to model.

System preparation: before docking, the protein and DNA/RNA structures are cleaned, formatted, and pre-processed. This may include removing water molecules, adding missing atoms, assigning charges, and defining flexible regions.

Docking calculation: the prepared protein and nucleic acid are virtually positioned in various orientations and conformations using computational algorithms. The goal is to simulate all possible ways they could interact in three-dimensional space.

Scoring: each predicted binding pose is evaluated using a scoring function, which estimates the binding affinity or stability of the complex. The scoring considers hydrogen bonds, hydrophobic contacts, electrostatic interactions, and steric fit.

Complexed structure: the best-scoring docked conformation is selected as the predicted complex. This is the computationally generated model of how the protein interacts with DNA/RNA as shown in Figure 7.

Interaction types in such complexes

When proteins bind to DNA/RNA, common interactions include:

• Hydrogen bonding (between amino acid side chains and nucleotide bases or the phosphate backbone)

• Electrostatic interactions (positive residues like Lys and Arg with negatively charged phosphate groups)

Van der Waals contacts:

• Base stacking (aromatic amino acids interacting with nucleobases)

6.2 Challenges in macromolecular docking

• Larger interfaces with extensive contact surfaces

• Significant conformational flexibility and induced fit upon binding

• Difficulties in accurately scoring and predicting binding affinity

• Presence of water molecules and cofactors affecting interactions

These complexities require specialized docking approaches and often integrate experimental data, such as mutagenesis or NMR restraints.

6.3 Docking approaches for protein–protein and protein–DNA complexes

• Rigid-body docking: assumes minimal conformational changes and uses shape complementarity to predict complex formation. Useful as a starting point.

• Flexible docking: incorporates side-chain or backbone flexibility using MD or ensemble docking techniques to capture induced fit.

• Template-based docking: uses known structures of similar complexes as models; helpful when homologous complexes are available.

6.4 Popular tools and algorithms

Several specialized software tools have been developed for macromolecular docking, including:

• High Ambiguity Driven DOCKing (HADDOCK): incorporates experimental data and flexible docking

• ClusPro: automated rigid-body protein–protein docking server

• ZDOCK: uses fast Fourier transform (FFT)-based rigid docking

• Rosetta dock: allows flexible docking with energy-based scoring

• 3D-DART: specialized for protein–DNA docking

6.5 Applications

• Predicting signaling complexes in pathways like MAPK and apoptosis

• Designing inhibitors that block protein–protein interfaces in diseases such as cancer

• Understanding transcription factor binding to DNA for gene regulation studies

• Engineering synthetic transcription factors or DNA-binding proteins for biotechnology

7.1 Molecular dynamics (MD) simulations

MD simulations model the time-dependent behavior of molecules by solving Newton’s equations of motion, allowing researchers to:

• Explore the conformational flexibility of both the ligand and the receptor

• Observe binding and unbinding events dynamically

• Refine docking poses by allowing the relaxation of complexes in a simulated environment

• Calculate binding free energies through techniques like MM-PBSA and MM-GBSA

By integrating docking with MD, scientists can better predict realistic binding modes and improve the reliability of docking outcomes.

7.2 Quantum mechanics/molecular mechanics (QM/MM) methods

QM/MM combines the accuracy of quantum mechanical calculations for the reactive site with the efficiency of MM for the rest of the system. This hybrid approach is particularly useful when:

• Studying enzyme catalysis and reaction mechanisms

• Investigating electronic effects in ligand binding

• Modeling bond formation/breaking events that classical docking cannot capture

QM/MM can complement docking by providing detailed insight into transition states and energy barriers, which are critical for enzyme engineering and drug design.

7.3 Workflow integration

A common workflow includes:

• Initial docking to predict binding poses

• MD simulations to relax and explore the dynamics of the docked complex

• QM/MM calculations on the active site or ligand-binding region to analyze electronic structure and reaction pathways

This multiscale modeling approach enhances predictive power and enables comprehensive mechanistic studies.

7.4 Advantages and challenges

Advantages:

• Accounts for molecular flexibility and solvent effects

• Provides detailed energetic and mechanistic information

• Improves the accuracy of binding affinity predictions

Challenges:

• High computational cost, especially for QM/MM

• Requires expertise to set up and interpret simulations

• Integration complexity and large data handling

8.1 Protein and ligand flexibility

One of the main challenges in docking is accurately accounting for the flexibility of both proteins and ligands. Most docking programs simplify the problem by treating the receptor as rigid or only partially flexible. However, proteins often undergo significant conformational changes upon ligand binding (induced fit), which rigid docking methods cannot capture effectively [19, 20]. Similarly, ligands with many rotatable bonds create an enormous conformational search space, complicating accurate predictions.

8.2 Scoring function limitations

Current scoring functions are approximate and often struggle to reliably predict absolute binding affinities or rank ligands correctly. They may:

• Overlook important entropic contributions

• Inaccurately model solvation and desolvation effects

• Fail to capture specific interactions, such as metal coordination or water-mediated hydrogen bonds

This can lead to false positives or negatives, affecting VS outcomes.

9.1 Artificial intelligence and machine learning integration

AI and ML are transforming docking by:

• Improving scoring functions using large datasets and pattern recognition

• Enhancing pose prediction accuracy through deep learning models

• Automating hit identification and lead optimization workflows

These approaches enable more reliable predictions with less human intervention, accelerating drug discovery.

9.2 Enhanced treatment of flexibility

Next-generation docking methods increasingly incorporate:

• Full protein and ligand flexibility through ensemble docking or MD-guided docking

• Modeling of induced fit and allosteric changes dynamically

• Use of coarse-grained models to efficiently explore large conformational spaces

This allows for more realistic simulations of molecular interactions.

9.3 Improved solvent and environment modeling

Explicit inclusion of water molecules and ions in docking simulations is becoming more common, helping to better capture the role of the solvent environment in binding.

9.3.3 Cloud computing and high-performance resources

Access to powerful cloud-based platforms and GPUs allows the screening of ultra-large libraries with advanced methods, democratizing docking for researchers worldwide.

A comparison chart (Figure 9) illustrating differences between organic and green solvents used in bio-oil extraction, showing contrasts in toxicity, environmental impact, extraction efficiency, cost, and sustainability, with green solvents highlighted as safer and more eco-friendly alternatives. Organic solvents are widely used in bio-oil extraction due to their efficiency and availability. These solvents are typically petroleum-derived and are effective in dissolving a wide range of bioactive compounds. However, their use raises environmental and human health concerns, such as toxicity, flammability, and contribution to pollution.

On the other hand, green solvents represent a more sustainable alternative. Derived from bio-based or renewable sources, green solvents are designed to be environmentally friendly, biodegradable, and less toxic. They reduce the ecological footprint of bio-oil extraction and align with the principles of green chemistry.

Despite their advantages, the application of green solvents faces challenges and limitations. These include higher costs, limited availability, and sometimes lower extraction efficiency compared to traditional organic solvents. Research efforts are increasingly directed toward overcoming these challenges through the development of novel green solvent systems, process optimization, and large-scale feasibility studies.

The Figure 9 highlights the trade-off between efficiency and sustainability in solvent selection, underlining the importance of future research and innovation to expand the applicability of green solvents in bio-oil extraction while minimizing environmental and health hazards.